Case Report, J Genet Disor Genet Rep Vol: 6 Issue: 3

Morbid Obesity and Psychiatric Disorders Hiding a Sex Aneuploidy: A Case of Late Diagnosis of 48,XXYY Syndrome

Antía Fernández-Pombo^1,2, Pablo San Millán-Tejedor³, Cristina Guillín-Amarelle^1,2, Ana I. Castro^2,4, Juan Carlos Guinarte-Cabada⁵, Margarita Ventura-Victoria,⁶ and David Araújo-Vilar^1,2*

¹UETeM-Molecular Pathology Group, Department of Medicine, IDIS-CIMUS, University of Santiago de Compostela, Spain

²Division of Endocrinology and Nutrition, University Clinical Hospital of Santiago de Compostela, Spain

³Division of Psychology, University Clinical Hospital of Santiago de Compostela, Spain

⁴CIBER Fisiopatología de la Obesidad y la Nutrición (CIBERobn), Madrid, Spain

⁵Division of Medical and Molecular Genetics, University Clinical Hospital of Santiago de Compostela, Spain

⁶Division of Radiodiagnosis, University Clinical Hospital of Santiago de Compostela, Spain

*Corresponding Author : David Araújo-Vilar
Department of Medicine-IDISCIMUS- Facultade de Medicina, University of Santiago de Compostela, Avda de Barcelona s/n-15707, Santiago de Compostela, Spain
Tel: +34-881815426
Fax: +34-981559937
E-mail: david.araujo@usc.es

Received: August 16, 2017 Accepted: September 20, 2017 Published: September 27, 2017

Citation: Fernández-Pombo A, Millán-Tejedor PS, Guillín-Amarelle C, Castro AI, Guinarte-Cabada JC, et al. (2017) Morbid Obesity and Psychiatric Disorders Hiding a Sex Aneuploidy: A Case of Late Diagnosis of 48,XXYY Syndrome. J Genet Disor Genet Rep 6:3. doi: 10.4172/2327-5790.1000162

Abstract

Keywords: 48,XXYY; Hypergonadotropic hypogonadism; Sex chromosomal aneuploidy; Morbid obesity

Introduction

48,XXYY syndrome is a rare sex chromosomal aneuploidy due to the addition of an extra X and Y chromosome to the 46,XY full-length karyotype. Originally described in 1960 as a variant of Klinefelter syndrome, to which it is phenotypically similar in many respects [1], it is now considered a distinct clinical and genetic entity, differentiating from the former due to a greater intellectual and psychiatric affectation [2]. In newborn screening studies, Klinefelter syndrome (47,XXY) is the most common chromosomal abnormality in human beings, with a prevalence of approximately 1:650 male births [3], whereas the 48,XXYY syndrome has a prevalence of 1:18.000 - 1:50.000 [4].

Case Report

A 37-year-old caucasian male, the second child born to a nonconsanguineous couple, with a brother with no medical history of interest, was referred from the Department of Psychiatry to our department due to morbid obesity. He had been diagnosed with schizotypal personality disorder, presenting heboid behaviour, as well as episodes of irritability and verbal and physical aggressiveness and a single suicide attempt through the ingestion of an industrial detergent. Among his antecedents, there are also several episodes of alcohol abuse in the past, the presence of enuresis until the age of 15, and onychophagy of the hands and feet. He currently has a sedentary life, with hardly any social relationships and only primary studies. He referred erectile dysfunction and absence of libido.

Among other alterations to be highlighted is a respiratory allergy due to sensitivity to dust mites, as well as a syncopal episode 3 years ago, with loss of consciousness for approximately 10 minutes duration, without loss of sphincter control, not classified as an epileptic crisis.

Physical examination showed a weight of 126 kg and a height of 175 cm, with a body mass index of 41.14 kg/m². Phenotypically (Figure 1), we observed dental irregularities, prognathism, facial acne, narrow shoulders and broad hips, generalized obesity, and pes planus. He presented eunuchoid habitus, with gynoid distribution of body hair, gynecomastia and microgenitalism, testicular volume of 6 ml measured by orchidometer, and microphallus . Moreover, bilateral symmetrical tremor with a postural and intentional component was observed.

Regarding the analytical data, the hemogram, hepatic profile, renal function, ions and lipid profile did not reveal alterations. As for the hormonal determinations, he presented hypergonadotropic hypogonadism, with testosterone 0.68 ng/ml, 17 beta-estradiol 12.4 pg/ml, FSH 32.5 IU/l, and LH 15.4 IU/l. Thyroid function was normal (TSH 2.48 mIU/l, T4 1.18 ng/dL, T3 3.76 pg/ml). Plasma glucose was 102 mg/dl, with glycosylated hemoglobin of 5.5%. With respect to bone markers, he showed calcium 8.8 mg/dl, phosphorus 3.4 mg/dl, PTH 59 pg/ml, 25-hydroxyvitamin D 6 ng/ml, alkaline phosphatase 190 IU/l, N-terminal telopeptide 0.83 ng/ml.

Chromosomal analysis performed with G-banding technique on lymphocytes from a peripheral blood sample, showed the presence of 48, XXYY in all the metaphases studied (Figure 2).

Given these findings, androgenic therapy was started with intramuscular testosterone, which had to be discontinued after several months due to overt hetero-aggressive behaviour.

An electroencephalogram was carried out, in which a wellintegrated tracing and no evaluable abnormalities were observed. Computed axial tomography and magnetic resonance imaging showed a small type I arachnoid cyst on the anterior slope of the left temporal lobe. The electrocardiogram describes sinus bradycardia with no other alterations, and no congenital cardiac defects were observed on the echocardiogram. Polysomnography revealed obstructive sleep apnoea syndrome. On the other hand, there were no renal or other viscera abnormalities in abdominal ultrasound. As for the ophthalmological evaluation, only myopia was observed as a refractive error, with a normal fundoscopic examination.

Bone densitometry was performed by whole-body dual-energy X-ray absorptiometry (DXA), showing a T-score of -1.2 in the lumbar spine, 0.8 in the femoral neck, 0.0 in the hip. Therefore, osteoporosis was discarded.

Regarding body composition through DXA, he principally showed a gynoid fat distribution, with total fat mass of 62.7 kg, 6.39 kg in upper limbs, 20.8 kg in lower limbs and 32.7 kg in the trunk. He also showed total lean mass of 55.3 kg, 6.01 kg in the upper limbs, 21.1 kg in the lower limbs and 24.3 kg in the trunk.

In the cognitive evaluation tests, using the Wechsler Adult Intelligence Scale (WAIS-IV), he obtained an IQ of 81 (95% CI 76- 88), corresponding to a low performance for the subject’s age. With respect to verbal comprehension, perceptual reasoning, working memory and processing speed indices, he showed a score of 1 SD below the mean, which puts our patient in the range of borderline intellectual functioning/normal range.

Discussion

48,XXYY syndrome has been identified as a variant of the Klinefelter syndrome due to the fact that they share a similar phenotype. However, because with each additional chromosome there is a greater incidence of physical, structural, and other long-term complications, it is now considered as a distinct clinical syndrome [2].

It is believed that most cases of 48,XXYY syndrome are the result of the fertilization of a normal oocyte with an aneuploid sperm produced through non-disjunction in both meiotic divisions I and II during spermatogenesis [5]. To date, studies of parental origin, performed in diagnosed cases of 48,XXYY have shown that additional X and Y chromosomes have a paternal origin [6], suggesting that the presence of these supernumerary sex chromosomes may lead to alterations in DNA methylation, which leads to altered gene expression and subsequent phenotypic differences.

Our patient was identified carrying the 48,XXYY chromosomopathy at the age of 37, although the vast majority of cases are diagnosed before adulthood. In fact, in the Tartaglia et al. multi-institutional study, over 70% of individuals with XXYY were diagnosed at pediatric age (prior to the age of 10) [7].

Physical characteristics are similar to Klinefelter syndrome, but with more pronounced phenotypic anomalies which vary with age. Hypertelorism, epicanthus, and upslanting palpebral fissures are often the most common features in childhood, although some, such as populated eyebrows and prominent mandible, emerge with age, while clinodactyly, pes planus and dental anomalies are common in all ages. 48,XXYY also affects male sexual development, manifesting microgenitalism, reduced facial and body hair and gynecomastia [6,7].

In addition, hyper gonadotropic hypogonadism involves an alteration of the body composition, as we have seen through DXA in our patient, with abdominal obesity and a predominance of gynoid fat distribution, on long-term this may lead to the onset of metabolic syndrome and peripheral insulin resistance [8].

Other associated features include peripheral vascular disease, deep vein thrombosis, renal anomalies, hypothyroidism, intentional tremor, allergy and asthma [7,9]. In addition, it has been seen that 48,XXYY syndrome has a particularly elevated incidence of non- Hodgkin lymphoma [10].

On the other hand, an increase in the incidence of congenital heart disease (tetralogy of Fallot, pulmonary valve stenosis, mitral valve prolapse, etc.) has been reported [7], but in our patient the cardiological study revealed no abnormalities.

High stature, related to the overexpression of the SHOX gene [11], is one of the most important physical findings in adults with 48,XXYY syndrome. In fact, the mean final adult height in XXYY is slightly taller than in XXY [7]. However, our patient is of normal stature. Therefore, the lack of a high stature should not exclude the diagnosis of 48,XXYY syndrome.

While mental deficiency is rarely is observed in Klinefelter syndrome, a high percentage of subjects with 48,XXYY syndrome have significantly lower IQ and almost all have learning difficulties [9]. This borderline or below normal IQ is justified by the polysomic X and the biased inactivation of the X chromosome. Psychiatric problems, manifested as aggressiveness, impulsivity with significant social difficulties and behavioural deficits, appear to be related to double sex chromosome aneuploidy [12,13]. Aggressive behaviour and an IQ of 81 in our patient, matched up with the psychiatric findings described previously for this syndrome.

Androgen therapy should be considered because, in addition to promoting the development and maintenance of secondary sexual characteristics, improving sexual function, increasing muscle mass and preventing the acquisition of excessively high stature, it also usually significantly improves mental, behavioural and bone health [9,14]. However, for those with significant mental health problems such as bipolar or psychotic disorders, or as in the case of our patient with a personality disorder, testosterone treatment should be initiated slowly with close observation by the mental health team [7]. In fact, this treatment in our case had to be suspended due to overt heteroaggressive behaviour.

In conclusion, for the diagnosis of 48,XXYY syndrome, it is important to perform a correct anamnesis and physical examination, since, as in the case of our patient, certain details may be overlooked, thereby leading to a late diagnosis. In this way, in subjects with mental health problems and the suspicion of a low IQ, as well as microgenitalism and eunuchoid habitus a karyotype should be done, with the objective of accomplishing the early diagnosis of this kind of aneuploidy. This would provide the patient with the necessary support at an early stage. On the other hand, it is necessary to emphasize that not every 48,XXYY subject will present tall stature and, therefore, a normal height should not exclude the diagnosis of this disease. Regarding the evaluation of a patient already diagnosed with XXYY, it is clear that a multidisciplinary approach ought to be employed. First of all, endocrinological assessment must be carried out in order to find hypogonadism, diabetes, obesity, hypothyroidism and osteoporosis. This should be followed by a neurological and psychiatric evaluation. The performance of a brain magnetic resonance imaging, an electroencephalogram and a polysomnography should also be strongly considered depending on clinical symptoms. Other tests such as an echocardiogram for the evaluation of congenital heart defects, a renal ultrasound, or an ophthalmological examination, should also be considered.

Informed Consent

Informed consent was obtained from the patient who participated in this study.

Conflicts of Interest

The authors have nothing to disclose.

References

1. Muldal S, Ockey CH (1960) The “double male”: a new chromosome constitution in Klinefelter’s syndrome. Lancet 276: 492-493.
2. Parker CE, Mavalwala J, Melnyk J, Fish CH (1970) The 48,XXYY syndrome. Am J Med 48: 777-781.
3. Evans JA, de von Flindt R, Greenberg C, Ramsay S, Hamerton JL (1982) A cytogenetic survey of 14,069 newborn infants. IV. Further follow-up on the children with sex chromosome anomalies. Birth Defects Orig Artic Ser 18: 169-184.
4. Sorensen K, Nielsen J, Jacobsen P, Rolle T (1978) The 48,XXYY syndrome. J Ment Defic Res 22: 197-205.
5. Hassold T, Hall H, Hunt P (2007) The origin of human aneuploidy: where we have been, where we are going. Hum Mol Genet 16: R203-R208.
6. Tartaglia N, Ayari N, Howell S, D’Epagnier C, Zeitler P (2011) 48,XXYY, 48,XXXY and 49,XXXXY syndromes: not just variants of Klinefelter syndrome. Acta Paediatr 100: 851-860.
7. Tartaglia N, Davis S, Hench A, Nimishakavi S, Beauregard R, et al. (2008) A new look at XXYY syndrome: Medical and Psychological features. Am J Med Genet A 146A: 1509-1522.
8. Bojesen A, Gravholt CH (2011) Morbidity and mortality in Klinefelter syndrome (47,XXY). Acta Paediatr 100: 807-813.
9. Visootsak J, Graham JM Jr (2006) Klinefelter syndrome and other sex chromosomal aneuploidies. Orphanet J Rare Dis 1: 42
10. Swerdlow AJ, Schoemaker MJ, Higgins CD, Wright AF, Jacobs PA (2005) Cancer incidence and mortality in men with Klinefelter syndrome: a cohort study. J Natl Cancer Inst 97: 1204-1210.
11. Munns CJ, Haase HR, Crowther LM, Hayes MT, Blaschke R, et al. (2004) Expression of SHOX in human fetal and childhood growth plate. J Clin Endocrinol Metab 89: 4130-4135.
12. Litsuka Y, Bock A, Nguyen DD, Samango-Sprouse CA, Simpson JL, et al. (2001) Evidence of skewed X-chromosome inactivation in 47,XXY and 48,XXYY Klinefelter patients. Am J Med Genet 98: 25-31.
13. Zelante L, Piemontese MR, Francioli G, Calvano S (2003) Two 48,XXYY patients: clinical, cytogenetic and molecular aspects. Ann Genet 46: 479-481.
14. Bhasin S, Cunningham GR, Hayes FJ, Matsumoto AM, Snyder PJ, et al. (2010) Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 95: 2536-2559.